FDCDDQ
RGC icon

Federation des caisses Desjardins du Quebec’s Regencell Bioscience RGC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
2,803
+572
+26% +$13.7K ﹤0.01% 2240
2026
Q1 		$56.7K Buy
+2,231
New +$63.1K ﹤0.01% 1826

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RGC Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Regencell Bioscience (RGC) stake by 26% in Q2 2026, buying an estimated $13.7K and bringing the position to 2,803 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

Federation des caisses Desjardins du Quebec first reported a position in RGC in Q1 2026 and has held it in 2 quarters since. The position peaked at $56.7K in Q1 2026. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 2,803 shares of Regencell Bioscience worth $17.1K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 572 Regencell Bioscience shares in Q2 2026, an estimated $13.7K.
  • Regencell Bioscience made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2240 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Regencell Bioscience in Q1 2026 and has held it in 2 quarters since.
  • Federation des caisses Desjardins du Quebec's Regencell Bioscience position peaked at $56.7K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.